Table 1. Treatments for scleroderma by level of evidence.
Treatment | Level of evidence |
---|---|
UVA-1 | 2 |
Methotrexate | 1 |
Mycophenolate mofetil | 1 |
Intravenous immunoglobulin | 2 |
Rituximab | 2 |
Abatacept | 1 |
Tocilizumab | 1 |
Level of evidence: 1, indicates randomized controlled trial; 2, uncontrolled trial.